DrugPatentWatch Database Preview
Details for Patent: 8,372,872
» See Plans and Pricing
Which drugs does patent 8,372,872 protect, and when does it expire?
Patent 8,372,872 protects ULORIC and is included in one NDA.
This patent has thirteen patent family members in eleven countries.
Summary for Patent: 8,372,872
| Title: | Methods for concomitant treatment of theophylline and febuxostat |
| Abstract: | Co-administration of febuxostat and theophylline to a hyperuricemic patient suffering from gout is disclosed. |
| Inventor(s): | Gunawardhana; Lhanoo (Pleasant Prairie, WI), Naik; Himanshu (Evanston, IL), Tsai; Max (Highland Park, IL) |
| Assignee: | Takeda Pharmaceuticals U.S.A., Inc. (Deerfield, IL) |
| Application Number: | 13/295,696 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,372,872 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 8,372,872
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Takeda Pharms Usa | ULORIC | febuxostat | TABLET;ORAL | 021856-001 | Feb 13, 2009 | AB | RX | Yes | No | Start Trial | Start Trial | Start Trial | ||||
| Takeda Pharms Usa | ULORIC | febuxostat | TABLET;ORAL | 021856-002 | Feb 13, 2009 | AB | RX | Yes | Yes | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,372,872
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2011299153 | Start Trial | |||
| Brazil | 112013005792 | Start Trial | |||
| Canada | 2812034 | Start Trial | |||
| China | 103298466 | Start Trial | |||
| European Patent Office | 2613780 | Start Trial | |||
| Spain | 2532210 | Start Trial | |||
| Hong Kong | 1189170 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
